Literature DB >> 16421161

Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.

Csaba P Kovesdy1, Bhairvi K Trivedi, Kamyar Kalantar-Zadeh, John E Anderson.   

Abstract

BACKGROUND: Blood pressure shows an inverse association with mortality in patients with chronic kidney disease (CKD) on dialysis. It is unclear if the same phenomenon exists in patients with CKD not yet on dialysis.
METHODS: We examined the association of systolic (SBP) and diastolic (DBP) blood pressure with all-cause mortality in a historical prospective cohort of 860 patients (age 68.1+/-10.1 years, 99.1% male, 24.4% black) with estimated glomerular filtration rate (GFR) < 60 ml/min/1.73 m2. We used Cox models to adjust for the effects of age, race, diabetes mellitus, atherosclerotic cardiovascular disease (ASCVD), congestive heart failure, smoking, antihypertensive medications, body mass index, GFR, albumin, cholesterol, haemoglobin and proteinuria. To examine the role of comorbidities, we performed subgroup analyses based on prevalent ASCVD status and level of estimated GFR.
RESULTS: Higher SBP and higher DBP were both associated with lower mortality [adjusted hazard ratio (95% confidence interval) for SBP 133-154, 155-170 and > 170 mmHg, compared with < 133 mmHg, respectively: 0.61 (0.44-0.85), 0.62 (0.45-0.87) and 0.68 (0.49-0.96); and for DBP 65-75, 76-86 and > 86 mmHg, compared with < 65 mmHg: 0.85 (0.62-1.18), 0.72 (0.52-1.00) and 0.60 (0.41-0.86)]. The same association was present for both SBP and DBP only in subgroups with GFR < or = 30 ml/min/1.73 m2 and for DBP only in the subgroup with ASCVD.
CONCLUSIONS: Lower blood pressure is associated with higher mortality in patients with moderate to severe CKD, but interactions with kidney function and with ASCVD suggest that blood pressure may play a surrogate rather than a causative role in this association.

Entities:  

Mesh:

Year:  2006        PMID: 16421161     DOI: 10.1093/ndt/gfk057

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  47 in total

1.  Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.

Authors:  Miklos Z Molnar; Lilia R Lukowsky; Elani Streja; Ramanath Dukkipati; Jennie Jing; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

2.  Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD.

Authors:  Csaba P Kovesdy; Olga Kuchmak; Jun Ling Lu; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2010-08-21       Impact factor: 8.860

3.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

4.  Increased cardiovascular risk associated with reduced kidney function.

Authors:  Timothy P Ryan; Susan G Fisher; Jessica L Elder; Paul C Winters; William Beckett; James Tacci; James A Sloand
Journal:  Am J Nephrol       Date:  2009-01-19       Impact factor: 3.754

5.  Prognosis of CKD patients receiving outpatient nephrology care in Italy.

Authors:  Luca De Nicola; Paolo Chiodini; Carmine Zoccali; Silvio Borrelli; Bruno Cianciaruso; Biagio Di Iorio; Domenico Santoro; Vincenzo Giancaspro; Cataldo Abaterusso; Ciro Gallo; Giuseppe Conte; Roberto Minutolo
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

6.  Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

Authors:  Csaba P Kovesdy; Vitalie Ureche; Jun L Lu; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2010-03-17       Impact factor: 5.992

Review 7.  What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?

Authors:  Yazan Khouri; Susan P Steigerwalt; Mershed Alsamara; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

8.  Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.

Authors:  Nisha Bansal; Eric Vittinghoff; Laura Plantinga; Chi-Yuan Hsu
Journal:  J Nephrol       Date:  2012 May-Jun       Impact factor: 3.902

Review 9.  Observational studies versus randomized controlled trials: avenues to causal inference in nephrology.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Adv Chronic Kidney Dis       Date:  2012-01       Impact factor: 3.620

10.  Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease.

Authors:  Csaba P Kovesdy; Olga Kuchmak; Jun L Lu; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.